The Effect of Reproductive Violence Education Given to Women on Perception of Violence, Conflict Resolution Styles and Awareness of Violence: A Randomized Controlled Trial

This study was planned as a methodological and randomized controlled experimental study to determine the effects of reproductive violence education given to women on women's perceptions of violence. H0a: There is no difference in the perception levels of reproductive violence between women who were given and those who were not given reproductive violence education. H1a: There is a difference in the perception levels of reproductive violence between women who were given and those who were not given reproductive violence education. H0b: There is no difference in the conflict resolution styles and violence awareness levels between women who were given and those who were not given reproductive violence education. H1b: There is a difference in the conflict resolution styles and violence awareness levels between women who were given and those who were not given reproductive violence education. In the second phase of the study, 4 hours of reproductive violence education will be given to women in the intervention group and brochures on reproductive violence will be distributed. The education will be held in the meeting hall of Hamidiye Faculty of Health Sciences in the form of a powerpoint presentation and case discussion. Before the training, the "Informed Consent Form", "Introductory Information Form", "Reproductive Violence Perception Form/Scale" and "Conflict and Violence Awareness Scale" will be applied to the intervention group. After the training, the "Reproductive Violence Perception Form/Scale" and "Conflict and Violence Awareness Scale" will be applied. As a follow-up test, the "Reproductive Violence Perception Form/Scale" and "Conflict and Violence Awareness Scale" will be applied after 4-6 weeks.

NCT Number	NCT06951529
Lead Sponsor	Saglik Bilimleri Universitesi
Conditions	Perception of Violence, Conflict Resolution Styles
Enrollment	80 participants
Start Date	2025-05-01
Primary Completion	2025-06-15 (estimated)
Study Completion	2025-09-15 (estimated)
Updated on ClinicalTrials.gov	2025-04-30